Cancer Drug Shortage Renews Calls for Federal Action

Cancer physicians across the United States face critical shortages of essential generic chemotherapy drugs, raising concerns about potential widespread drug rationing. According to reporting from The New York Times, oncologists are struggling to secure vital treatment options for their patients. The shortage threatens to compromise cancer care delivery and may force difficult treatment decisions. This crisis has reinvigorated calls for federal intervention to address systemic vulnerabilities in the pharmaceutical supply chain and ensure consistent access to life-saving medications.